News
Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy - Scientific Reports
23+ hour, 46+ min ago (1121+ words) The aim of this study is to examine cytokines and ICM as potential pre-treatment predictors for AIT-success in patients with grass and/or birch allergy. A secondary aim is to see if we can find clusters within the subjects, that…...
Machine Learning Pinpoints Immunotherapy Targets, Validated by Tumor
5+ hour, 53+ min ago (778+ words) In a groundbreaking advancement at the intersection of artificial intelligence and oncology, researchers have unveiled a pioneering method that harnesses machine learning to accelerate immunotherapy drug target discovery. This multidisciplinary approach not only streamlines the identification of promising therapeutic candidates…...
Cancer's own bacteria inspired a therapy that cuts off the tumor's power supply
7+ hour, 56+ min ago (821+ words) Hidden inside some tumors is an entire microbial population living within the cancer cells themselves. At first, researchers assumed those bacteria were biologically irrelevant " neither helping nor hurting. One team suspected they were something more. They went looking through the…...
A revolutionary discovery in cancer treatment independent of organ origin
8+ hour, 36+ min ago (160+ words) Davis Joseph was awarded the 2025 Ciechanover International Biology Award at the Sustainability through Science and Technology Summit 2025 (FLOGEN SIPS 2025) in Cebu, Philippines, for a breakthrough cancer discovery proposing organ-agnostic treatment strategies. His work identifies three universal cancer types based on…...
Defra Invites Public Feedback on Genetically Modified Bordetella pertussis Field Trial by ILi AD Biotechnologies and h VIVO Services - News and Statistics
15+ hour, 6+ min ago (437+ words) Public Consultation Open for GMO Field Trial Application 26/R59/01 Index Box Search across reports, market insights, and blog stories. Public Consultation Open for GMO Field Trial Application 26/R59/01 A public consultation has been opened regarding an application to conduct a field trial…...
Nano-scale Materials Boost Antitumor Immunity
12+ hour, 18+ min ago (707+ words) Cancer immunotherapy has revolutionized oncology, empowering the immune system to detect and dismantle malignancies that once evaded traditional treatments. Despite remarkable breakthroughs, a significant proportion of tumors remain impervious to immune eradication, cloaked behind a series of biological defenses. These…...
DNA-PK Phosphorylates CRTC2, Boosting NHEJ and Evading Immunity
10+ hour, 6+ min ago (875+ words) In a groundbreaking study set to redefine our understanding of DNA repair and its intersection with cancer immunity, researchers have uncovered the pivotal role of DNA-PK-mediated phosphorylation of CRTC2 in orchestrating non-homologous end joining (NHEJ) and modulating antitumor immune responses. This…...
Ubi Vac Adds Immunotherapy Pioneer Walter Urba to Scientific Advisory Board
12+ hour, 58+ min ago (423+ words) citybiz Ubi Vac Inc. has appointed veteran cancer immunotherapy researcher Walter J. Urba, M. D. , Ph. D. , to its Scientific Advisory Board as the company advances late-stage development of its off-the-shelf cancer vaccine platform targeting so-called "Dark Matter" tumor antigens. The move adds a…...
IU cancer center researchers show oxygen levels significantly alter stem cell behaviors
13+ hour, 6+ min ago (340+ words) Meagan Capitano, Mark Kaplan and James Ropa use the Hypoxia Core lab. Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that human hematopoietic stem cells are highly sensitive to oxygen, which can dictate how…...
Kali Therapeutics Announces Oral Presentation of KT502, a Novel CD19 x CD3 T-Cell Engager, at the EULAR 2026 Annual Congress
16+ hour, 44+ min ago (167+ words) May 18, 2026, 07: 01 ET The oral presentation will detail data demonstrating KT502's performance in in-vitro assays and non-human primate (NHP) models. Central to the program's success is Kali's proprietary masking design, which enables a wide therapeutic index by decoupling potent B-cell lysis…...